Open Access. Powered by Scholars. Published by Universities.®
Medicinal and Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Chapman University (82)
- University of Tennessee Health Science Center (14)
- Ohio Northern University (7)
- Virginia Commonwealth University (5)
- University of Kentucky (3)
-
- University of Nebraska Medical Center (3)
- Dominican University of California (2)
- Loma Linda University (2)
- Purdue University (2)
- Rowan University (2)
- Seton Hall University (2)
- University of Nebraska - Lincoln (2)
- American University in Cairo (1)
- Arcadia University (1)
- Chulalongkorn University (1)
- Claremont Colleges (1)
- Eastern Illinois University (1)
- Greater Baltimore Medical Center (1)
- Harding University (1)
- Harrisburg University of Science and Technology (1)
- Indiana State University (1)
- Kennesaw State University (1)
- Marshall University (1)
- Missouri State University (1)
- Nova Southeastern University (1)
- Old Dominion University (1)
- Otterbein University (1)
- Rochester Regional Health (1)
- Roseman University of Health Sciences (1)
- Southeastern University (1)
- Keyword
-
- Alzheimer’s disease (7)
- COVID-19 (5)
- Inflammation (4)
- Pharmacokinetics (4)
- AIDS (3)
-
- Alzheimer's disease (3)
- Antioxidants (3)
- CD44 (3)
- Diabetes (3)
- Drug delivery (3)
- Gout (3)
- HIV (3)
- Humans (3)
- Neurodegenerative disorders (3)
- PRG4 (3)
- Prodrugs (3)
- Reactive oxygen species (3)
- Remdesivir (3)
- Vaccines (3)
- Xanthine oxidase (3)
- 1 (2)
- Alcohol (2)
- Antibiotics (2)
- Antimalarials (2)
- Antimicrobial peptides (2)
- Apoptosis (2)
- Artemisinins (2)
- Artificial tears (2)
- Asthma (2)
- Blood–brain barrier (2)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (76)
- Theses and Dissertations (ETD) (14)
- Pharmacy and Wellness Review (6)
- Theses and Dissertations (6)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (3)
-
- Theses & Dissertations (3)
- Theses and Dissertations--Pharmacy (3)
- Loma Linda University Electronic Theses, Dissertations & Projects (2)
- Natural Sciences and Mathematics | Faculty Scholarship (2)
- Seton Hall University Dissertations and Theses (ETDs) (2)
- Advances in Clinical Medical Research and Healthcare Delivery (1)
- Annual Research Symposium (1)
- CONRAD Publications (1)
- Capstone Showcase (1)
- College of Science & Mathematics Departmental Research (1)
- Dissertations and Theses (Open Access) (1)
- Electronic Theses and Dissertations (1)
- Faculty Research and Publications (1)
- Graduate Student Theses, Dissertations, & Professional Papers (1)
- Graduate Theses/Dissertations (1)
- Harrisburg University Faculty Works (1)
- Honors Program: Senior Projects (Public) (1)
- Honors Undergraduate Theses (1)
- Journal of Community Hospital Internal Medicine Perspectives (1)
- Journal of Humanities and Social Sciences (1)
- Makara Journal of Science (1)
- Mako: NSU Undergraduate Student Journal (1)
- Master's Theses (1)
- Masters Theses (1)
- Mathematics, Physics, and Computer Science Faculty Articles and Research (1)
- Publication Type
Articles 151 - 157 of 157
Full-Text Articles in Medicinal and Pharmaceutical Chemistry
Pharmacokinetic And Pharmacodynamic Studies Of A Novel Spectinamide Series Of Antituberculosis Agents, V. N. R. Pavan Kumar Vaddady
Pharmacokinetic And Pharmacodynamic Studies Of A Novel Spectinamide Series Of Antituberculosis Agents, V. N. R. Pavan Kumar Vaddady
Theses and Dissertations (ETD)
Spectinamides are novel amide derivatives of the antibiotic spectinomycin that have emerged as a new class of agents to treat tuberculosis. These agents showed potent in vitro activity against Mycobacterium tuberculosis (MTB) compared to spectinomycin and in a preliminary in vivo study in interferon gamma (IFN‑γ) knockout mice, spectinamide Lee1329 reduced the lung bacillary load of TB comparable to streptomycin. We hypothesized that the application of an iterative pharmacokinetics and pharmacodynamics (PK/PD) guided approach would facilitate the optimization of these lead compounds suitable for further development.
A series of in vitro experiments including parallel artificial membrane permeability assay (PAMPA), microsomal …
Synthesis Of 3-Phenylpyrazolopyrimidine-1,2,3-Triazole Conjugates And Evaluation Of Their Src Kinase Inhibitory And Anticancer Activities, Anil Kumar, Israr Ahmad, Bhupender S. Chhikara, Rakesh Tiwari, Deendayal Mandal, Keykavous Parang
Synthesis Of 3-Phenylpyrazolopyrimidine-1,2,3-Triazole Conjugates And Evaluation Of Their Src Kinase Inhibitory And Anticancer Activities, Anil Kumar, Israr Ahmad, Bhupender S. Chhikara, Rakesh Tiwari, Deendayal Mandal, Keykavous Parang
Pharmacy Faculty Articles and Research
A series of two classes of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates were synthesized using click chemistry approach. All compounds were evaluated for inhibition of Src kinase and human ovarian adenocarcinoma (SK-Ov-3), breast carcinoma (MDA-MB-361), and colon adenocarcinoma (HT-29). Hexyl triazolyl-substituted 3-phenylpyrazolopyrimidine exhibited inhibition of Src kinase with an IC50 value of 5.6 µM. 4-Methoxyphenyl triazolyl-substituted 3-phenylpyrazolopyrimidine inhibited the cell proliferation of HT-29 and SK-Ov-3 by 73% and 58%, respectively, at a concentration of 50 µM.
Preliminary Studies Into Dna Binding Capabilities Of Ruthenium Nitro Nitrosyl As Anti-Tumor Pro-Drugs, Natasha Hansson
Preliminary Studies Into Dna Binding Capabilities Of Ruthenium Nitro Nitrosyl As Anti-Tumor Pro-Drugs, Natasha Hansson
Seton Hall University Dissertations and Theses (ETDs)
The complex [Ru(bpy)z(NO)(N02)](PF6)2 was investigated as a potential anti tumor drug option. The nitrosyl group was displaced by reaction with azide ion in acetone to yield the solvento complex in situ. The products isolated from addition of a solution or slurry of guanine, adenine, cytosine or thiamine to the resulting [Ru(bpy)(N02)(acetone)t were investigated by electronic absorption spectroscopy, infra 1 red spectroscopy, H NMR spectroscopy and cyclic voltammetry. The results of the studies showed that guanine, adenine and thiamine form adducts with Ru(bpy)z(N02)(acetone)t. However, each base forms a unique complex as shown by electronic spectroscopy. Guanine is the strongest field ligand, …
Helical Peptides Derived From Lactoferrin Bind Hepatitis C Virus Envelope Protein E2, Reem Beleid, Donna Douglas, Norman Kneteman, Kamaljit Kaur
Helical Peptides Derived From Lactoferrin Bind Hepatitis C Virus Envelope Protein E2, Reem Beleid, Donna Douglas, Norman Kneteman, Kamaljit Kaur
Pharmacy Faculty Articles and Research
Hepatitis C virus is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma infecting more than 170 million people. Hepatitis C virus envelope 2 glycoprotein (E2) binds several cell‐surface molecules that act as receptor candidates mediating hepatitis C virus entry into hepatocytes. Peptides derived from human lactoferrin have been shown to bind hepatitis C virus‐E2 protein thereby preventing hepatitis C virus entry in cultured hepatocytes. In this study, starting from a 33‐residue human lactoferrin‐derived peptide, a number of biotin‐linked α‐peptides were synthesized and investigated for their E2 protein binding activity. E2 protein from hepatitis C virus genotype 1b …
Oxidative Stress-Mediated Anticancer Activity Of Novel Ahr Modulators Af & 5f203, Lancelot S. Mclean
Oxidative Stress-Mediated Anticancer Activity Of Novel Ahr Modulators Af & 5f203, Lancelot S. Mclean
Loma Linda University Electronic Theses, Dissertations & Projects
Estrogen receptor positive (ER+) breast cancer tends to respond to anti-estrogen agents such as Tamoxifen. Approximately 40% of ER+ breast cancer is resistant to these agents and those that initially respond often acquire resistance. Estrogen receptor negative (ER-) breast cancer remains largely unresponsive to these agents. It is therefore vital to discover drugs that are potent in both forms of breast cancer. Aminoflavone, (5-amino-2, 3-fluorophenyl)-6,8-difluoro-7-methyl-4H-l-benzopyran-4-one; AF; NSC 686288) and 5F203, (2-[-Amino-3-methy phenyl]-5-flurobenzothiazole) are novel anticancer candidate agents that display potent in vitro and in vivo anti-proliferative activity against select human tumor cells with a unique anticancer activity profile in the …
Composites Comprising Cholesterol And Carboxymethyl Cellulose, Vuk Uskoković
Composites Comprising Cholesterol And Carboxymethyl Cellulose, Vuk Uskoković
Pharmacy Faculty Articles and Research
Whereby cholesterol presents one of the major fatty substances in human body, carboxymethyl cellulose is a water-soluble derivative of cellulose, the most abundant dietary fiber. Whereas on one hand in vivo precipitation of cholesterol is the major cause of atherosclerosis, dietary fibers are on the other hand known for their ability to clean the fatty plaque deposited on intestinal pathways, and prevent its build-up in other critical areas within the organism. In this work, a method for the preparation of a composite material comprising cholesterol and carboxymethyl cellulose from 1-hexanol/water biphase mixtures is reported. Specificity of the interaction between the …
The Role Of Multi-Drug Resistance Associated Protein 4 And P-Glycoprotein In Resistance Of Neuroblastoma To Topotecan And Irinotecan, Patricia Kellie Turner
The Role Of Multi-Drug Resistance Associated Protein 4 And P-Glycoprotein In Resistance Of Neuroblastoma To Topotecan And Irinotecan, Patricia Kellie Turner
Theses and Dissertations (ETD)
High-risk neuroblastoma presents a significant therapeutic challenge because the 5-year survival rate remains less than 30% despite the use of surgery, multi-agent chemotherapy, radiation, and autologous bone marrow transplant. Novel therapeutic modalities are under development. The camptothecin analogs topotecan and irinotecan have been identified as successful cytotoxic agents. For topotecan, pharmacokinetically guided dosing to achieve a systemic exposure associated with preclinical anti-tumor activity in neuroblastoma xenograft models is feasible and has elicited favorable responses in children with high-risk neuroblastoma. However, some children with high-risk disease did not respond to the putatively effective topotecan systemic exposure. These children represent a subset …